Skip to main content

previous disabled Page of 2
and
  1. No Access

    Chapter

    Disorders of Monoamine Metabolism

    Neurotransmitters include the catecholamines (dopamine, norepinephrine, and epinephrine) and the indoleamines (serotonin and melatonin). They are chemical messengers, which mediate, amplify, or modulate synapt...

    Thomas Opladen, Georg F. Hoffmann in Physician's Guide to the Diagnosis, Treatm… (2022)

  2. No Access

    Chapter

    Cerebral Organic Acid Disorders and Other Disorders of Lysine Catabolism

    Twelve inborn errors of metabolism are described in this chapter. Glutaric aciduria type I, L-2-hydroxyglutaric aciduria, D-2-hydroxyglutaric aciduria (type I and II), D-2−/L-2-hydroxyglutaric aciduria, N-acet...

    Stefan Kölker, Georg F. Hoffmann in Inborn Metabolic Diseases (2022)

  3. No Access

    Chapter

    Kreatinmangelsyndrome

    Kreatinmangelsyndrome werden durch 3 monogene Defekte der Synthese oder des zellulären Imports von Kreatin verursacht. Seit der Erstbeschreibung 1994 wurden ungefähr 100 Patienten diagnostiziert. Hierbei wurde...

    Georg F. Hoffmann in Pädiatrie (2020)

  4. No Access

    Chapter

    Defekte der Cholesterolbiosynthese

    Defekte der Cholesterolbiosynthese sind die ersten monogenen Erbkrankheiten, die als Ursache embryofetaler Fehlbildungssyndrome nachgewiesen wurden. Ein einziger Enzymdefekt ist im proximalen Teil des Synthese...

    Georg F. Hoffmann in Pädiatrie (2020)

  5. No Access

    Chapter

    Aminoazidopathien

    Gemeinsames biochemisches Merkmal aller angeborenen Aminoazidopathien, die durch angeborene Defekte spezifischer Enzyme und Transporter verursacht werden, ist die Akkumulation charakteristischer Aminosäuren un...

    Stefan Kölker, Georg F. Hoffmann in Pädiatrie (2020)

  6. No Access

    Chapter

    Differenzialdiagnose und Notfallbehandlung von Intermediärstoffwechselkrankheiten

    Immer mehr angeborene Stoffwechselkrankheiten sind erfolgreich behandelbar. Umso wichtiger ist es, die Diagnose zeitnah zu stellen, da jegliche Verzögerung des Therapiebeginns schwere irreversible Folgeschäden...

    Georg F. Hoffmann, Stefan Kölker in Pädiatrie (2020)

  7. No Access

    Chapter

    Organoazidurien

    Organoazidurien sind eine ätiologisch heterogene Gruppe angeborener Stoffwechselerkrankungen: Sie unterscheiden sich weder hinsichtlich ihrer Ätiologie noch ihrer Pathogenese grundsätzlich von den Aminoazidopa...

    Stefan Kölker, Georg F. Hoffmann in Pädiatrie (2020)

  8. No Access

    Chapter

    A Homozygous Splice Site Mutation in SLC25A42, Encoding the Mitochondrial Transporter of Coenzyme A, Causes Metabolic Crises and Epileptic Encephalopathy

    SLC25A42 is an inner mitochondrial membrane protein which has been shown to transport coenzyme A through a lipid bilayer in vitro. A homozygous missense variant in this gene has been recently reported in 13 su...

    Arcangela Iuso, Bader Alhaddad, Corina Weigel in JIMD Reports, Volume 44 (2019)

  9. No Access

    Chapter

    Neurotransmitter Defects and Related Disorders

    Monogenic defects of neurotransmission have become recognized as causes of severe, progressive encephalopathies mostly of early onset. The clinical presentation can be quite distinctive. Patients suffering fro...

    Georg F. Hoffmann in Inherited Metabolic Diseases (2017)

  10. No Access

    Chapter

    Patient Care and Treatment

    Care and treatment of patients with an inherited metabolic disease require both a detailed knowledge of the natural history of the diseases and a comprehensive understanding of the molecular basis and the path...

    William L. Nyhan, Georg F. Hoffmann in Inherited Metabolic Diseases (2017)

  11. No Access

    Chapter

    Metabolic Emergencies

    The driving force in the early recognition and treatment of metabolic emergencies is the maintenance of a suspicion that such a disorder may be the underlying cause. The classic presentation of inborn errors o...

    William L. Nyhan, Stefan Kölker, Georg F. Hoffmann in Inherited Metabolic Diseases (2017)

  12. No Access

    Chapter

    Workup of the Patient with Lactic Acidemia: Mitochondrial Disease

    Genetically determined causes of lactic acidemia fall into two categories: abnormalities in gluconeogenesis and defects of oxidative phosphorylation or mitochondrial disease. This distinction is important beca...

    William L. Nyhan, Stefan Kölker, Georg F. Hoffmann in Inherited Metabolic Diseases (2017)

  13. No Access

    Chapter

    Approach to the Child Suspected of Having a Disorder of Fatty Acid Oxidation

    Hypoketotic hypoglycemia signifies a disorder of fatty acid oxidation. An absence of ketones in urine at the time of hypoglycemia is an important clue, but the presence of ketonuria may be misleading. Blood le...

    William L. Nyhan, Stefan Kölker, Georg F. Hoffmann in Inherited Metabolic Diseases (2017)

  14. No Access

    Chapter

    Work-Up of the Patient with Acute Neurological or Psychiatric Manifestations

    Many inherited metabolic diseases lead to neurologic or psychiatric manifestations, often as the leading symptoms. A substantial number of patients present with acute encephalopathy to emergency departments wh...

    William L. Nyhan, Stefan Kölker, Georg F. Hoffmann in Inherited Metabolic Diseases (2017)

  15. No Access

    Chapter

    Inherited Metabolic Diseases in the Context of Rare/Orphan Diseases

    Inherited metabolic diseases have changed from a limited group of rare, untreatable, often fatal disorders to an important cause of acutely life-threatening and increasingly treatable diseases. Unchanged is th...

    Georg F. Hoffmann in Inherited Metabolic Diseases (2017)

  16. No Access

    Chapter

    Workup of the Patient with Metabolic Acidosis and Massive Ketosis

    Massive ketosis in a neonate or young infant is a key to the diagnosis of a classic organic aciduria. The initial episode may begin with vomiting, anorexia, and lethargy, but progresses rapidly to life-threate...

    William L. Nyhan, Stefan Kölker, Georg F. Hoffmann in Inherited Metabolic Diseases (2017)

  17. No Access

    Chapter

    Work-Up of the Patient with Hypoglycemia

    Hypoglycemia must be recognized promptly and treated effectively, if permanent damage to the brain is to be prevented. Rational treatment demands a specific diagnosis of the disease causing the hypoglycemia. T...

    William L. Nyhan, Stefan Kölker, Georg F. Hoffmann in Inherited Metabolic Diseases (2017)

  18. No Access

    Chapter

    Work-Up of the Patient with Hyperammonemia

    Hyperammonemia is the hallmark of the disorders of the urea cycle but occurs episodically also in organic acidurias and disorders of fatty acid oxidation. Routine clinical chemistry is helpful in pointing the ...

    William L. Nyhan, Stefan Kölker, Georg F. Hoffmann in Inherited Metabolic Diseases (2017)

  19. No Access

    Chapter

    Emergency Treatment of Inherited Metabolic Diseases

    In patients at risk for acute metabolic decompensation, timely intervention during the initial presentation of metabolic imbalance and during later metabolic crises precipitated by dietary indiscretion or inte...

    William L. Nyhan, Stefan Kölker, Georg F. Hoffmann in Inherited Metabolic Diseases (2017)

  20. No Access

    Chapter

    Newborn Screening Programmes in Europe, Arguments and Efforts Regarding Harmonisation: Focus on Organic Acidurias

    Background: The state of newborn screening (NBS) programmes for organic acidurias in Europe was assessed by a web-based questionnaire in the EU programme of Community Action in Public Health 2010/2011 among the –...

    Friederike Hörster, Stefan Kölker, J. Gerard Loeber in JIMD Reports, Volume 32 (2017)

previous disabled Page of 2